A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase
Koichi Nisijima, Katutoshi Shioda Department of Psychiatry, Jichi Medical University, Tochigi, Japan Abstract: Neuroleptic malignant syndrome (NMS) is a life-threatening adverse reaction to antipsychotic drugs. Although there is no specific examination able to diagnose NMS, serum creatine kinase (...
Main Authors: | Nisijima K, Shioda K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/a-rare-case-of-neuroleptic-malignant-syndrome-without-elevated-serum-c-a15943 |
Similar Items
-
Temporal changes in serum creatine kinase concentration and degree of muscle rigidity in 24 patients with neuroleptic malignant syndrome
by: Nisijima K, et al.
Published: (2013-06-01) -
Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases
by: Nisijima K
Published: (2012-12-01) -
Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson's disease
by: Wei L, et al.
Published: (2014-02-01) -
Neuroleptic malignant syndrome
by: Mariana Moscovich, et al.
Published: (2011-10-01) -
Neuroleptic malignant syndrome
by: Bino Rajamani, et al.
Published: (2016-01-01)